Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Biochemistry

• Publication date

  1995-02-21

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI00007A003PMID 7532003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids.

  2009cited by this paper
• Solid-phase synthesis of a range of O-phosphorylated peptides by post-assembly phosphitylation and oxidation.

  2009cited by this paper
• Peptide inhibitors of src SH3-SH2-phosphoprotein interactions.

  1995cited by this paper
• Involvement of pp60c-src with two major signaling pathways in human breast cancer.

  1994cited by this paper
• Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.

  1994cited by this paper
• Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav

  1994cited by this paper
• Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide.

  1994cited by this paper
• Thermodynamic studies of tyrosyl-phosphopeptide binding to the SH2 domain of p56lck.

  1994cited by this paper
• SH2 domain specificity and activity modified by a single residue

  1994cited by this paper
• Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation.

  1994cited by this paper
• Csk inhibition of c‐Src activity requires both the SH2 and SH3 domains of Src.

  1993cited by this paper
• SH2 and SH3 domains.

  1993cited by this paper
• The when and how of Src regulation.

  1993cited by this paper
• Exploring the limits of precision and accuracy of protein structures determined by nuclear magnetic resonance spectroscopy.

  1993cited by this paper
• A general method for assigning NMR spectra of denatured proteins using 3D HC(CO)NH-TOCSY triple resonance experiments

  1993cited by this paper
• Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck

  1993cited by this paper
• Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides

  1993cited by this paper
• Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance.

  1993cited by this paper
• Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae

  1993cited by this paper
• The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy.

  1993cited by this paper
• Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms.

  1993cited by this paper
• Amino acid type determination in the sequential assignment procedure of uniformly 13C/15N-enriched proteins

  1993cited by this paper
• Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR.

  1993cited by this paper
• Three-dimensional solution structure of the src homology 2 domain of c-abl.

  1992cited by this paper
• Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product.

  1992cited by this paper
• Conformation of two non‐immunosuppressive FK506 analogs when bound to FKBP by isotope‐filtered NMR

  1992cited by this paper
• Structure of an SH2 domain of the p85 alpha subunit of phosphatidylinositol-3-OH kinase.

  1992cited by this paper
• NMR structure determination in solution: a critique and comparison with X-ray crystallography.

  1992cited by this paper
• The src family of tyrosine protein kinases in hemopoietic signal transduction

  1992cited by this paper
• SH2 and SH3 domains: from structure to function.

  1992cited by this paper
• The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison with X‐ray structures

  1992cited by this paper
• Secondary structure of Src homology 2 domain of c-Abl by heteronuclear NMR spectroscopy in solution.

  1992cited by this paper
• Side chain and backbone assignments in isotopically labeled proteins from two heteronuclear triple resonance experiments

  1992cited by this paper
• Four-dimensional 13C/13C-edited nuclear Overhauser enhancement spectroscopy of a protein in solution: application to interleukin 1 beta.

  1991cited by this paper
• SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins.

  1991cited by this paper
• Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons

  1991cited by this paper
• Oncogenes and signal transduction.

  1991cited by this paper
• Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src.

  1991cited by this paper
• Uniform 13C isotope labeling of proteins with sodium acetate for NMR studies: application to human carbonic anhydrase II.

  1991cited by this paper
• Identification and localization of bound internal water in the solution structure of interleukin 1 beta by heteronuclear three-dimensional 1H rotating-frame Overhauser 15N-1H multiple quantum coherence NMR spectroscopy.

  1990cited by this paper
• Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis.

  1990cited by this paper
• Four-dimensional heteronuclear triple-resonance NMR spectroscopy of interleukin-1 beta in solution.

  1990cited by this paper
• Stereospecific nuclear magnetic resonance assignments of the methyl groups of valine and leucine in the DNA-binding domain of the 434 repressor by biosynthetically directed fractional 13C labeling.

  1989cited by this paper
• pp60c-src activation in human colon carcinoma.

  1989cited by this paper
• Overcoming the overlap problem in the assignment of 1H NMR spectra of larger proteins by use of three-dimensional heteronuclear 1H-15N Hartmann-Hahn-multiple quantum coherence and nuclear Overhauser-multiple quantum coherence spectroscopy: application to interleukin 1 beta.

  1989cited by this paper
• Determination of three‐dimensional structures of proteins from interproton distance data by hybrid distance geometry‐dynamical simulated annealing calculations

  1988cited by this paper
• Activation of pp60c-src protein kinase activity in human colon carcinoma.

  1987cited by this paper
• Human cellular src gene: nucleotide sequence and derived amino acid sequence of the region coding for the carboxy-terminal two-thirds of pp60c-src

  1985cited by this paper
• Activation of the pp60c‐src kinase by middle T antigen binding or by dephosphorylation.

  1985cited by this paper
• Pseudo-structures for the 20 common amino acids for use in studies of protein conformations by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance.

  1983cited by this paper

• A Story of Kinases and Adaptors: The Role of Lck, ZAP-70 and LAT in Switch Panel Governing T-Cell Development and Activation

  2023cites this paper
• How the Discovery of the CD4/CD8-p56lck Complexes Changed Immunology and Immunotherapy

  2021cites this paper
• Estrogen Receptor Folding Modulates cSrc Kinase SH2 Interaction via a Helical Binding Mode.

  2015cites this paper
• N-Terminal Acetylation of Phosphopeptides to Enhance the Interaction with SH2 Domain by Electrosprary Ion Trap Mass Spectrometry

  2015cites this paper
• The Src SH2 domain interacts dynamically with the focal adhesion kinase binding site as demonstrated by paramagnetic nmr spectroscopy

  2012cites this paper
• Two Closely Spaced Tyrosines Regulate NFAT Signaling in B Cells via Syk Association with Vav

  2011cites this paper
• , Association with Vav NFAT Signaling in B Cells via Syk Two Closely Spaced Tyrosines Regulate

  2011cites this paper
• Simultaneous binding of two peptidyl ligands by a SRC homology 2 domain.

  2011cites this paper
• Conformational Determinants of Phosphotyrosine Peptides Complexed with the Src SH2 Domain

  2010influential citation
• Constraining binding hot spots: NMR and molecular dynamics simulations provide a structural explanation for enthalpy-entropy compensation in SH2-ligand binding.

  2010cites this paper
• A Novel Conserved Phosphotyrosine Motif in the Drosophila Fibroblast Growth Factor Signaling Adaptor Dof with a Redundant Role in Signal Transmission

  2010cites this paper
• SH2 domain binding to phosphopeptide ligands: potential for drug targeting.

  2009cites this paper
• Solution structure and membrane interactions of the antimicrobial peptide fallaxidin 4.1a: an NMR and QCM study.

  2009cites this paper
• Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling.

  2009cites this paper
• Spectroscopic Characterization of the SH2- and Active Site-Directed Peptide Sequences of a Bivalent Src Kinase Inhibitor

  2009cites this paper
• Surface movement in water of splendipherin, the aquatic male sex pheromone of the tree frog Litoria splendida

  2008cites this paper
• Structure, dynamics, and binding thermodynamics of the v‐Src SH2 domain: Implications for drug design

  2008cites this paper
• Structural basis for the binding of high affinity phosphopeptides to Stat3

  2008cites this paper
• Comparison of composer and ORCHESTRAR

  2008cites this paper
• Solid Phase Synthesis of Phosphopeptides Incorporating 2,2-Dimethyloxazolidine Pseudoproline Analogs: Evidence for trans Leu-Pro Peptide Bonds in Stat3 Inhibitors

  2007cites this paper
• 2.15 – Peptidomimetic and Nonpeptide Drug Discovery: Receptor, Protease, and Signal Transduction Therapeutic Targets

  2007cites this paper
• Amphibian skin peptides which inhibit nNOS : structure and binding studies using heteronuclear NMR

  2006cites this paper
• The Jak1 SH2 Domain Does Not Fulfill a Classical SH2 Function in Jak/STAT Signaling but Plays a Structural Role for Receptor Interaction and Up-regulation of Receptor Surface Expression*

  2005cites this paper
• Noncovalent binding between guanidinium and anionic groups: focus on biological- and synthetic-based arginine/guanidinium interactions with phosph[on]ate and sulf[on]ate residues.

  2005cites this paper
• Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor.

  2005cites this paper
• Protein-Protein Recognition in Phosphotyrosine-Mediated Intracellular Signaling

  2005cites this paper
• Solution studies of the SH2 domain from the fyn tyrosine kinase: secondary structure, backbone dynamics and protein association

  2004cites this paper
• Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.

  2004cites this paper
• Investigating the importance of the flexible hinge in caerin 1.1: solution structures and activity of two synthetically modified caerin peptides.

  2004cites this paper
• Solution Structure of the C-terminal Domain of the Ciliary Neurotrophic Factor (CNTF) Receptor and Ligand Free Associations among Components of the CNTF Receptor Complex*

  2003cites this paper
• The solution structure of frenatin 3, a neuronal nitric oxide synthase inhibitor from the giant tree frog, Litoria infrafrenata.

  2003cites this paper
• Electrostatic interactions in the reconstitution of an SH2 domain from constituent peptide fragments

  2003cites this paper
• The solution structures and activity of caerin 1.1 and caerin 1.4 in aqueous trifluoroethanol and dodecylphosphocholine micelles

  2003cites this paper
• Sequence, structure and energetic determinants of phosphopeptide selectivity of SH2 domains.

  2003cites this paper
• nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications. The solution structure of a modified citropin 1.1.

  2003cites this paper
• Molecular and biophysical analysis of the non-catalytic PH, TH, SH3 and SH2 domains of Bruton tyrosine kinase (Btk) protein

  2002cites this paper
• Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide

  2002cites this paper
• A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor.

  2002cites this paper
• Calorimetric and structural studies of 1,2,3-trisubstituted cyclopropanes as conformationally constrained peptide inhibitors of Src SH2 domain binding.

  2002cites this paper
• Pulse Sequences for Measuring Coupling Constants

  2002cites this paper
• Molecular and biochemical characterization of suppressor of cytokine signaling-3 (SOCS-3) and SH2-containing phosphatase 1 (SHP-1) in the context of G-CSF) and erythropoietin signaling

  2002cites this paper
• Improved convergence of binding affinities with free energy perturbation: Application to nonpeptide ligands with pp60src SH2 domain

  2001cites this paper
• Glycosylated and phosphorylated proteins--expression in yeast and oocytes of Xenopus: prospects and challenges--relevance to expression of thermostable proteins.

  2001cites this paper
• Inhibitors to the Src SH2 domain: a lesson in structure--thermodynamic correlation in drug design.

  2001cites this paper
• Reconstitution of a native‐like SH2 domain from disordered peptide fragments examined by multidimensional heteronuclear NMR

  2001cites this paper
• How Macromolecules Associate

  2001cites this paper
• The solution structure of the cytokine-binding domain of the common beta-chain of the receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 and interleukin-5.

  2000cites this paper
• Comparison of binding energies of SrcSH2‐phosphotyrosyl peptides with structure‐based prediction using surface area based empirical parameterization

  2000cites this paper
• Isotope-filtered NMR methods for the study of biomolecular structure and interactions

  2000cites this paper
• Maculatin 1.1, an anti-microbial peptide from the Australian tree frog, Litoria genimaculata solution structure and biological activity.

  2000cites this paper
• The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.

  2000cites this paper
• Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.

  1999cites this paper
• The solution structure of uperin 3.6, an antibiotic peptide from the granular dorsal glands of the Australian toadlet, Uperoleia mjobergii.

  1999cites this paper
• Peptidomimetic Ligands for Src Homology-2 Domains

  1999cites this paper
• Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements.

  1999cites this paper
• The formation of a covalent complex between a dipeptide ligand and the src SH2 domain.

  1998cites this paper
• Determining the structures of large proteins and protein complexes by NMR.

  1998cites this paper
• Solution and solid state conformation of the human EGF receptor transmembrane region.

  1998cites this paper
• Potent antagonists of the SH2 domain of Grb2: optimization of the X+1 position of 3-amino-Z-Tyr(PO3H2)-X+1-Asn-NH2.

  1998cites this paper
• How and why phosphotyrosine-containing peptides bind to the SH2 and PTB domains.

  1998cites this paper
• SH2- and SH3-mediated Interactions between Focal Adhesion Kinase and Src*

  1998cites this paper
• Conformation of an Shc-derived phosphotyrosine-containing peptide complexed with the Grb2 SH2 domain

  1997cites this paper
• pH Titration studies of an SH2 domain‐phosphopeptide complex: Unusual histidine and phosphate pKa values

  1997cites this paper
• Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study.

  1997cites this paper
• Three-dimensional structure of the Hck SH2 domain in solution

  1997cites this paper
• Heteronuclear NMR studies of the combined Src homology domains 2 and 3 of pp60 c-Src: effects of phosphopeptide binding.

  1997cites this paper
• The influence of a scalar-coupled deuterium upon the relaxaton of a 15N Nucleus and its possible exploitation as a probe for side-chain interactions in proteins.

  1997cites this paper
• Design of peptidomimetic ligands for the pp60src SH2 domain.

  1997cites this paper
• Modular peptide recognition domains in eukaryotic signaling.

  1997cites this paper
• Thermodynamic and structural analysis of phosphotyrosine polypeptide binding to Grb2-SH2.

  1997cites this paper
• The Role of 4-phosphonodifluoromethyl- and 4-phosphono-phenylalanine in the selectivity and cellular uptake of SH2 domain ligands

  1997cites this paper
• The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity.

  1997cites this paper
• Nonphosphorylated Peptide Ligands for the Grb2 Src Homology 2 Domain*

  1997cites this paper
• Structural aspects of signal transduction in B-cells.

  1996cites this paper
• NMR analysis of interactions of a phosphatidylinositol 3'-kinase SH2 domain with phosphotyrosine peptides reveals interdependence of major binding sites.

  1996cites this paper
• Chemical shift assignments and secondary structure of the Grb2 SH2 domain by heteronuclear NMR spectroscopy

  1996cites this paper
• Nuclear magnetic resonance solution structure of the growth factor receptor-bound protein 2 Src homology 2 domain.

  1996cites this paper
• Systematic Mapping of Potential Binding Sites for Shc and Grb2 SH2 Domains on Insulin Receptor Substrate-1 and the Receptors for Insulin, Epidermal Growth Factor, Platelet-derived Growth Factor, and Fibroblast Growth Factor (*)

  1996cites this paper
• Structure of a specific peptide complex of the carboxy‐terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3‐kinase.

  1996cites this paper
• The three-dimensional solution structure of the SH2 domain from p55blk kinase.

  1996cites this paper
• Catalytic specificity of phosphotyrosine kinases Blk, Lyn, c-Src and Syk as assessed by phage display.

  1996cites this paper
• Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution.

  1996cites this paper
• Novel phosphotyrosine mimetics in the design of peptide ligands for pp60src SH2 domain

  1996cites this paper
• Structural basis for specificity of GRB2-SH2 revealed by a novel ligand binding mode

  1996cites this paper
• Phosphotyrosyl Peptide-Enzyme Complexes: How Much Structure Can We Get From Transferred Noe’s

  1996cites this paper
• Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.

  1995cites this paper
• Structures of protein complexes by multidimensional heteronuclear magnetic resonance spectroscopy.

  1995cites this paper
• Chapter 24. SH2 and SH3 Domains: Choreographers of Multiple Signaling Pathways

  1995cites this paper
• Structure-activity studies of phosphorylated peptide inhibitors of the association of phosphatidylinositol 3-kinase with PDGF-beta receptor.

  1995cites this paper
• Solution structure of a band 3 peptide inhibitor bound to aldolase: a proposed mechanism for regulating binding by tyrosine phosphorylation.

  1995cites this paper
• Structure-activity studies of phosphorylated peptide inhibitors of the association of phosphatidylinositol 3-kinase with PDGF-β receptor

  1995cites this paper